Nonapeptide ethylamide inhibitors of the luteinizing hormone-releasing hormone (LH-RH) having a D-alanyl residue in position 6 and variations at positions 2 and 3
- 1 December 1977
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 20 (12) , 1674-1677
- https://doi.org/10.1021/jm00222a028
Abstract
A series of 10 analogues, of structure des-Gly10-[amino acid2,amino acid3,D-Ala6]-LH-RH ethylamide, was synthesized by solid-phase methods. L-Aromatic and alkylamino acids were substituted into position 2 and alkylamino acids into position 3. Highest in vitro inhibition of LH-RH action was obtained with analogues having aromatic residues in position 2. Des-Gly10-[Trp2,Leu3,D-Ala6]-LH-RH ethylamide inhibited the action of 0.6 ng/ml of LH-RH in an isolated pituitary [rat] assay at a dosage as low as 1 .mu.g/ml, and the corresponding Phe2 analogue inhibited the effect of 0.3 ng of LH-RH at 0.1 .mu.g/ml. The Trp2 analogue inhbited ovulation in rats at the dosage of 1.5 mg/rat.This publication has 4 references indexed in Scilit:
- Peptide hormones. 95. Inhibition of the activity of the luteinizing hormone-releasing hormone (LH-RH) by analogs with variations at positions 2, 3, and 6 and the carboxyl terminusJournal of Medicinal Chemistry, 1977
- Presence of proline in positions 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulationBiochemical and Biophysical Research Communications, 1976
- Contraception and inhibition of ovulation by minipump infusion of the luteinizing hormone releasing hormone, active analogs and antagonistsBiochemical and Biophysical Research Communications, 1976
- A Peptide Inhibitor of Luteinizing Hormone-Releasing Hormone (LH-RH)Journal of Clinical Endocrinology & Metabolism, 1973